Piper Sandler Maintains Overweight on RingCentral, Lowers Price Target to $75
Piper Sandler analyst James Fish maintains RingCentral (NYSE:RNG) with a Overweight and lowers the price target from $118 to $75.
Top 5 Mid-Cap Momentum Stocks To Gain Defying Volatility
Severe volatility in the U.S. stock markets since the beginning of this year has been showing no sign of abatement. U.S. stocks have corrected significantly so far in 2022 after a fabulous rally in the last two pandemic-ridden years.
Industrial REITs Poised To Shine On Robust Demand: 4 Key Players
The industrial real estate asset category has been, undoubtedly, playing a crucial role for the past few years in the growing e-commerce market, transforming how consumers shop and receive their goods. Moreover, the companies are making immense efforts to improve supply-chain efficiencies, propelling demand for logistics infrastructure and efficient distribution networks.
Cathie Wood Concerned That $22,500 Is Bitcoin’s New Resistance
Ark Invest founder Cathie Wood addressed the fears associated with the “systemic collapse” of the crypto ecosystem on Tuesday.
UBS Maintains Buy on FMC, Lowers Price Target to $140
UBS analyst Joshua Spector maintains FMC (NYSE:FMC) with a Buy and lowers the price target from $149 to $140.
Morgan Stanley Maintains Overweight on NexTier Oilfield, Lowers Price Target to $12
Morgan Stanley analyst Connor Lynagh maintains NexTier Oilfield (NYSE:NEX) with a Overweight and lowers the price target from $12.5 to $12.
Morgan Stanley Maintains Overweight on Schlumberger, Lowers Price Target to $45
Morgan Stanley analyst Connor Lynagh maintains Schlumberger (NYSE:SLB) with a Overweight and lowers the price target from $50 to $45.
5 Dividend Stocks That Promise Solid Growth
Heightened volatility and uncertainty in the stock market triggered by decades-high inflation, the Russia-Ukraine conflict and Fed's aggressive tightening policy have compelled investors to search for consistent income. In this regard, nothing is better than dividend investing.
Expert Ratings for Gilead Sciences
Analysts have provided the following ratings for Gilead Sciences (NASDAQ:GILD) within the last quarter:
Morgan Stanley Maintains Overweight on Liberty Energy, Lowers Price Target to $20
Morgan Stanley analyst Connor Lynagh maintains Liberty Energy (NYSE:LBRT) with a Overweight and lowers the price target from $23 to $20.